C

CASI Pharmaceuticals Inc
NASDAQ:CASI

Watchlist Manager
CASI Pharmaceuticals Inc
NASDAQ:CASI
Watchlist
Price: 5.75 USD 3.6%
Market Cap: 77.1m USD
Have any thoughts about
CASI Pharmaceuticals Inc?
Write Note

CASI Pharmaceuticals Inc
Accumulated Depreciation

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

CASI Pharmaceuticals Inc
Accumulated Depreciation Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Accumulated Depreciation Analysis
Latest Figures & CAGR of Competitors

Company Accumulated Depreciation CAGR 3Y CAGR 5Y CAGR 10Y
C
CASI Pharmaceuticals Inc
NASDAQ:CASI
Accumulated Depreciation
-$4.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-37%
Abbvie Inc
NYSE:ABBV
Accumulated Depreciation
-$7.1B
CAGR 3-Years
-8%
CAGR 5-Years
-5%
CAGR 10-Years
-4%
Gilead Sciences Inc
NASDAQ:GILD
Accumulated Depreciation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Accumulated Depreciation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Accumulated Depreciation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Accumulated Depreciation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is CASI Pharmaceuticals Inc's Accumulated Depreciation?
Accumulated Depreciation
-4.7m USD

Based on the financial report for Dec 31, 2023, CASI Pharmaceuticals Inc's Accumulated Depreciation amounts to -4.7m USD.

What is CASI Pharmaceuticals Inc's Accumulated Depreciation growth rate?
Accumulated Depreciation CAGR 10Y
-37%

Over the last year, the Accumulated Depreciation growth was -102%.

Back to Top